Cosmax K-Beauty Fuels 35% US Revenue Jump

Walk into any TikTok-famous beauty store in Los Angeles or New York, and there’s a decent chance the serum on the shelf — whatever the brand name — was manufactured by a single Korean company most shoppers have never heard of. Cosmax, the world’s No. 1 cosmetics ODM (original design manufacturer), is quietly powering the K-beauty revolution from behind the scenes. And the numbers are starting to look extraordinary.

US Sales Surge 35% — Breakeven in Sight

Kyobo Securities forecasts Cosmax’s consolidated Q1 2026 revenue at 660 billion won (approximately $480 million), up 12% year-on-year. Operating profit is expected to reach 55 billion won, a 7% increase. Both figures are in line with market consensus.

However, the real story is in the United States. The US subsidiary is projected to post 35% revenue growth compared to the same period last year. Skincare and color cosmetics both contributed evenly — a sign of genuine breadth, not just a single-category spike. In addition, the pipeline is filling fast: inquiries for K-beauty concept product development have surged, pointing to further momentum ahead.

The US unit has also been narrowing its quarterly losses. As a result, analysts now consider breakeven — the point where revenue covers all costs — a near-term reality rather than a distant target. That shift alone changes the investment thesis for Cosmax considerably.

The US operation is no longer a drag. It is becoming a growth engine.

Domestic and China Units Hold Steady

Back home in Korea, Cosmax’s domestic subsidiary is expected to report revenue of 410 billion won, up 13%, with operating profit rising 5% to 35.9 billion won. Growth is led by skincare orders from indie brand clients, including The Founders and APR (the company behind Medicube). These so-called indie brands — smaller, direct-to-consumer labels that have gained outsized global followings — have become a defining customer segment for Cosmax.

Meanwhile, the China business also continues its double-digit expansion. The Shanghai subsidiary benefits from strong performance among key clients and channel diversification. The Guangzhou unit, by contrast, is expanding its customer base across online retail, offline stores, and export channels. Together, both Chinese operations are forecast to grow revenue by 13%.

Nevertheless, not every region is thriving. Southeast Asian subsidiaries — particularly Indonesia — face a tough comparison against last year’s high base, compounded by intensifying local competition. Revenue from that region is expected to fall roughly 15%.

Cosmax K-Beauty and the Broader Export Boom

Cosmax’s trajectory mirrors a wider national trend. Korea’s total cosmetics exports rose 19% year-on-year in Q1 2026. Shipments to the United States, in particular, jumped 40% — a re-acceleration that few analysts anticipated this quickly. For context, Korea’s annual cosmetics exports hit a record $11.4 billion in 2025.

The export structure itself is shifting. For years, China dominated Korea’s cosmetics export map. Now, the US and Europe are absorbing a growing share, reducing single-market dependency and adding resilience to the entire supply chain — including Cosmax’s order book.

Korea’s cosmetics industry is no longer China-dependent. That structural shift is a feature, not a footnote.

Why This Matters for Investors

Cosmax operates as an ODM, meaning it handles both product development and manufacturing on behalf of brand clients. This model differs from a simple contract manufacturer (OEM), which only produces what the client designs. As a result, Cosmax sits closer to the value chain’s creative core — and captures higher margins when trends move fast, as K-beauty currently is.

Kyobo Securities analyst Kwon Woo-jung notes that global cosmetics industry conditions remain healthy, and that Cosmax is well-positioned to capture direct upside from rising K-beauty demand, given its ODM leadership. Hanwha Investment Securities adds that new client acquisitions in the US market, combined with strong K-beauty tailwinds, support growth above 30% in the region.

Furthermore, the order mix is evolving. Large global cosmetics conglomerates — the kind that once relied on European or American ODM suppliers — are increasingly turning to Cosmax. Orders are also expanding beyond color cosmetics into skincare, a category with higher complexity and typically better margins.

For investors watching Korea’s export economy, Cosmax functions as a high-fidelity proxy for global K-beauty demand. Therefore, its quarterly results are worth tracking closely — not just as a single-company story, but as a barometer for where the broader trend is heading.

When the world buys K-beauty, Cosmax usually makes it. That position is increasingly hard to replicate.